Cargando…
Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results
Autores principales: | Sánchez-Martínez, Francesca, Arenas-Miras, Mar, Jové-Caballé, Neus, Knobel-Freud, Hernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SEPAR. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881697/ https://www.ncbi.nlm.nih.gov/pubmed/34629655 http://dx.doi.org/10.1016/j.arbres.2021.02.003 |
Ejemplares similares
-
Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
por: Kadkhoda, Kamran, et al.
Publicado: (2023) -
QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
por: Kim, Soo Han, et al.
Publicado: (2020) -
Serial Assays of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in Subjects Exposed to Patients with Active Tuberculosis
por: Moon, Hee-Won, et al.
Publicado: (2020) -
Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases
por: Ahn, Sung Soo, et al.
Publicado: (2021) -
QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-tube assays for
detecting latent tuberculosis infection in Thai healthcare
workers
por: Rudeeaneksin, Janisara, et al.
Publicado: (2023)